Patient education for the prevention of diabetic foot ulcers
Interim analysis of a randomised controlled trial due to morbidity and mortality of participants
DOI:
https://doi.org/10.1002/edn.189Keywords:
diabetes mellitus, diabetic foot ulcers, neuropathy, patient education, randomised controlled trialAbstract
AbstractThis study was designed to explore whether participant-driven patient education in group sessions, compared to provision of standard information, will contribute to a statistically significant reduction in new ulceration during 24 months in patients with diabetes and high risk of ulceration. This is an interim analysis after six months.
A randomised controlled study was designed in accordance with CONSORT criteria. Inclusion criteria were: age 35–79 years old, diabetes mellitus, sensory neuropathy, and healed foot ulcer below the ankle; 657 patients (both male and female) were consecutively screened.
A total of 131 patients (35 women) were included in the study. Interim analysis of 98 patients after six months was done due to concerns about the patients’ ability to fulfil the study per protocol. After a six-month follow up, 42% had developed a new foot ulcer and there was no statistical difference between the two groups. The number of patients was too small to draw any statistical conclusion regarding the effect of the intervention. At six months, five patients had died, and 21 had declined further participation or were lost to follow up. The main reasons for ulcer development were plantar stress ulcer and external trauma.
It was concluded that patients with diabetes and a healed foot ulcer develop foot ulcers in spite of participant-driven group education as this high risk patient group has external risk factors that are beyond this form of education. The educational method should be evaluated in patients with lower risk of ulceration.
Downloads
References
International Working Group on the Diabetic Foot. International Consensus on the Diabetic Foot. Consultative Section of International Diabetes Federation, 2007.
International Diabetes Federation. Diabetes Education Modules. 2006.
American Diabetes Association. Executive Summary: Standards of Medical Care in Diabetes - 2008. Diabetes Care 2008;31 (Suppl 1) :S5–S11.
Dorresteijn J, Kriegsman D, Assendelft W, et al. Patient education for preventing diabetic foot ulceration. Cochrane Database Syst Rev 2010(5).
Malone J, Snyder M, Anderson G, et al. Prevention of amputation by diabetic education. Am J Surgery 1989;158:520–4.
Vatankhah N, Khamseh ME, Jahangiri Noudeh Y, et al. The effectiveness of foot care education on people with type 2 diabetes in Tehran, Iran. Prim Care Diabetes 2009;3:73–7.
Lincoln N, Radford K, Game F, et al. Education for secondary prevention of foot ulcers in people with diabetes: a randomised controlled trial. Diabetologia 2008;51:1954–61.
Barth R, Campbell LV, Allen S, et al. Intensive education improves knowledge, compliance, and foot problems in type 2 diabetes. Diabet Med 1991;8:111–7.
Bloomgarden ZT, Karmally W, Metzger MJ, et al. Randomized, controlled trial of diabetic patient education: improved knowledge without improved metabolic status. Diabetes Care 1987;10:263–72.
Corbett CE A randomized pilot study of improving foot care in home health patients with diabetes. Diabetes Educ 2003;29:273–82.
Rönnemaa T, Hamalainen H, Toikka T, et al. Evaluation of the impact of podiatrist care in the primary prevention of foot problems in diabetic subjects. Diabetes Care 1997;20: 1833–7.
Kruger S GD. Foot care: knowledge retention and self-care practices. Diabetes Educ 1992;18:487–90.
Litzelman DK, Slemenda CW, Langefeld CD, et al. Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus: a randomized, controlled trial. Ann Intern Med 1993;119: 36–41.
Mazzuca SA, Moorman NH, Wheeler ML, et al. The diabetes education study: a controlled trial of the effects of diabetes patient education. Diabetes Care 1986;9:1–10.
Williams B, Pace AE. Problem based learning in chronic disease management: A review of the research. Patient Educ Couns 2009;77:14–9.
Funnell MM, Brown TL, Childs BP, et al. National standards for diabetes self-management education. Diabetes Care 2011;34 (Suppl 1):589–96.
Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357: 1191–4.
Wagner FW. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 1981;2:64–122.
Hjelm K, Nyberg P, Apelqvist J. Gender influences beliefs about health and illness in diabetic subjects with severe foot lesions. J Adv Nurs 2002;40:673–84.
Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 1990;13:513–21.
Reiber GE, Smith DG, Wallace C, et al. Effect of therapeutic footwear on foot reulceration in patients with diabetes: a randomized controlled trial. JANIA 2002;287:2552–8.
Swedish National Diabetes Register. Questionnaire for yearly control registration. Pappersblankett [paper registration questionnaire] 2008. https://www.ndr.nu/pdf/ndr_blankett_2011.pdf.
Consensus Committee. Consensus statement on the worldwide standardization of the hemoglobin Al C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care 2007;30 (9): 2399–400.
Apelqvist J, Agardh CD. The association between clinical risk factors and outcome of diabetic foot ulcers. Diabetes Res Clin Pract 1992;18: 43–53.
De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2003;24:1601–10.
Boulton AJ, Kubrusly DB, Bowker JH, et al. Impaired vibratory perception and diabetic foot ulceration. Diabet Med 1986;3:335–7.
Apelqvist J, Larsson J. What is the most effective way to reduce incidence of amputation in the diabetic foot? Diabetes Metab Res Rev 2000;16 (Suppl 1):S75–83.
Gershater MA, Löndahl M, Nyberg P, et al. Complexity of factors related to outcome of neuropathic and neuroischaemic diabetic foot ulcers: a cohort study. Diabetologia 2009;52; 398–407.
Larsson J, Agardh CD, Apelqvist J, et al. Clinical characteristics in relation to final amputation level in diabetic patients with foot ulcers: a prospective study of healing below or above the ankle in 187 patients. Foot Ankle Int 1995;16:69–74.
WorldMedicalAssociation.Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. 2008.
Larsson J, Agardh CD, Apelqvist J, et al. Long-term prognosis after healed amputation in patients with diabetes. Clin Orthop Relat Res 1998;(350): 149–58.
Iversen MM, Tell GS, Riise T, et al. History of foot ulcer increases mortality among individuals with diabetes. Diabetes Care 2009;32:2193–9.
Apelqvist J, Larssosn J, Agardh CD. Long-term prognosis for diabetic patients with foot ulcers. J Int Med 1993;233:485–91.
Boyko EJ, Ahroni JH, Cohen V, et al. Prediction of diabetic foot ulcer occurrence using commonly available clinical information: The Seattle Diabetic Foot Study. Diabetes Care 2006;29:1202–7.
Ghanassia E, Villon L, Thuan dit Dieudonne J, et al. Long-term out-come and disability of diabetic patients hospitalized for diabetic foot ulcers. Diabetes Care 2008;31: 1288–92.
Prompers L, Huijberts M, Apelqvist J, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 2007; 50:18–25.
Tesfaye S, Boulton AJM, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010;33:2285–93.
Leksell JK, Sandberg GE, Wikblad KF. Self-perceived health and self-care among diabetic subjects with defective vision: A comparison between subjects with threat of blindness and blind subjects. J Diabetes Complications 2005;19:54–9.
Cavanagh PR, Bus SA. Off-loading the diabetic foot for ulcer prevention and healing. J Vascular Surgery 2010;9;52(3, Suppl 1):37S–43S.
National Board of Health, DACEHTA. Diabetic foot ulcers - a health technology assessment. Copenhagen: National Board for Health, Danish Centre of Health Technology Assessment (DACEHTA), 2011. Health Technology Assessment 2011; 13(2).
Jeffcoate W. Stratification of foot risk predicts the incidence of new foot disease, but do we yet know that the adoption of routine screening reduces it? Diabetologia 2011;54: 991–3.
Socialstyrelsen. Nationella riktlinjer för diabetesvarden 2010 — stöd fOr styrning och ledning. Stockholm: Socialstyrelsen; 2010. [National Board of Health and Welfare. National Guidelines for Diabetes Care 2010 - support for control and management.]
McInnes A, Jeffcoate W, Vileikyte L, et al. Foot care education in patients with diabetes at low risk of complications: a consensus statement. Diabet Med 2011;28: 162–7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2011 Copyright © 2011 FEND
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
